Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results> Kintor Pharmaceutical (09939.HK) Full-year Loss Expands to RMB200 Million
Recommend 5 Positive 1 Negative 5 |
||||
|
||||
|
Kintor Pharmaceutical-B (09939.HK) announced its financial results for the fiscal year 2025, reporting revenue of RMB32.62 million, representing a year-on-year increase of 553.6%. The loss expanded from RMB155 million in the previous year to RMB200 million, with a loss per share of RMB0.44. No final dividend will be distributed. (de/d) Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
